A Periodical for the Sarcoma Community

July 2014 - Volume 11, Number 4

Preparing for a Transition

Editorial by Bruce and Beverly Shriver

Increasing Sarcoma Awareness

Letter to the Editor: Dr. CR Chandrasekar highlights the importance of sarcoma awareness and discusses strategies for improving it.

Prospective Biomarkers for Chemotherapy Selection in Sarcoma

A.D. Schenone and Dr. Brian Van Tine review the literature to identify validated biomarkers of the chemotherapies that are used for sarcoma treatment.

The Immune System and Chondrosarcoma's Response to Targeted Therapy

Experimental Plan: Investigators Dutor and Blay aim to characterize the chondrosarcoma immunological niche and determine its potential role in tumor progression and response to targeted therapy.

Translational Research in Well- and De-Differentiated Liposarcoma: Part II

Experimental Plan: Investigators Myklebost, Thomas, Meza-Zepeda and Wagner continue their research addressing key questions in liposarcoma.


$108,640 Grant on Immunology in Chondrosarcoma

The Liddy Shriver Sarcoma Initiative is funding a new study on chondrosarcoma.

$250,000 International Collaborative Grant on Liposarcoma

The Liddy Shriver Sarcoma Initiative and the Wendy Walk announce an International Collaborative Grant for research on well-differentiated and dedifferentiated liposarcomas.

A Translated Article

Tumore Maligno delle Guaine Nervose Periferiche (MPNST)

Dr. Marilena Cesari provides an Italian translation of the ESUN review article on malignant peripheral nerve sheath tumor.